Pacific Shuanglin Bio-pharmacy Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 1,049.937 million compared to CNY 915.656 million a year ago. Operating income was CNY 220.295 million compared to CNY 180.038 million a year ago. Net income was CNY 185.965 million compared to CNY 160.448 million a year ago. Basic earnings per share from continuing operations was CNY 0.3797 compared to CNY 0.328 a year ago. Diluted earnings per share from continuing operations was CNY 0.3793 compared to CNY 0.328 a year ago.